???global.info.a_carregar???
Marina Pinheiro (MP) is an Investigator in the Faculty of Pharmacy, University of Porto, a Public Health Resident Medical Doctor in ARS Norte (USP Cávado III). MP holds a Master's Degree in Medicine from the Faculty of Medicine, a Master's Degree in Pharmaceutical Sciences from the University of Porto, and also an European Doctorate Degree in Medicinal Chemistry. MP was an Assistant Professor in the Faculty of Pharmacy, University of Porto, and a Postdoctoral Fellowship in the Medicinal Chemistry field. MP authored 60 publications in prestigious refereed books and journals, most in top journals (Q1) in several fields, including Advanced Drug Delivery Reviews and Lancet. The scientific impact and quality of these publications have given her more than 7k citations and an h-index of 31 (Scopus), being cited in scientific papers for several top journals, such as Nature Microbiology and Chemical Reviews. MP presented her research in more than 90 national and international conferences (Turkey, USA, China, Israel, France, Austria, Germany, and Spain) with more than 30 oral presentations and more than 60 posters. MP research involves an interdisciplinary approach, combining the synthesis of novel drug delivery systems of anti-infectious and anti-cancer drugs to increase the therapeutic index of the drugs and improve the treatment of infectious diseases (TB, COVID-19, toxoplasmosis, HIV, malaria). MP is involved in several projects (>11), and has been in collaboration with dozens of national and international research groups. From 2018-2022, MP was a Principal Investigator in the Nano-TB project. MP is also a Management Committee Member of Cost Action CA18233 and a Member of the Cost Action ADVANCE-TB (CA21164) and CA18233. MP did several scientific internships, at the Max Planck Institute Berlin, the University of Cordoba Spain, King's College London, and Adolphe Merkel Institute Switzerland, among others. For the last 5 years, MP supervised 11 BSc, 2 MSc, 3 PhD, and 1 Postdoctoral researcher. MP is also a member of post-graduation juries, including a Doctorate jury. Since 2019, MP is also a supervisor member of the International Doctoral Programme in Molecular and Cellular Biotechnology Applied to Health Sciences. MP also serves as Academic Editor in several journals, including Plos One, Frontiers, Acta Médica Portuguesa, Cancers,, and has been active in the communication of science to the population, being a Member of the Communication group of the Portuguese Public Health Medical Association since 2022. MP has been a Consultant for the Science Fund of the Republic of Serbia and for the Lithuanian Research Council since 2021. Since 2023, MP has been an Expert in Mission HADEA (HORIZON) of the European Commission in Brussels, being also an Expert in the ERA4Health call. In 2024, MP was appointed a Technical Advisor of the Word Health Organization (WHO) in the Division of UHC/Healthier Populations.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Marina Barroso Pereira Pinheiro
Data de nascimento
1985/10/31
Género
Feminino

Nomes de citação

  • Pinheiro, Marina

Identificadores de autor

Ciência ID
ED16-98DD-AFA6
ORCID iD
0000-0002-6931-1355

Endereços de correio eletrónico

  • mbpinheiro@arsnorte.min-saude.pt (Profissional)
  • marinabppinheiro@gmail.com (Pessoal)

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Química Médica
  • Ciências Exatas - Química - Química Física
  • Ciências Médicas e da Saúde - Medicina Básica - Farmacologia e Farmácia
  • Ciências Médicas e da Saúde - Ciências da Saúde - Saúde Pública e Saúde Ambiental
  • Ciências Médicas e da Saúde - Ciências da Saúde - Doenças Infeciosas
  • Ciências Médicas e da Saúde - Ciências da Saúde - Saúde Pública e Saúde Ambiental

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Inglês Utilizador independente (B2) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Francês Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1)
Espanhol; Castelhano Utilizador elementar (A2) Utilizador elementar (A2) Utilizador elementar (A1) Utilizador independente (B1)
Formação
Grau Classificação
2023/01/10 - 2023/12/29
Concluído
 Curso de especialização em Saúde Pública (Diploma de especialização)
Universidade do Porto Instituto de Saúde Pública, Portugal
 17.6 (0-20 values)
2021/03 - 2021/05
Concluído
 Travel Medicine and Migration Medicine Course (Pós-Graduação)
Universidade do Porto Faculdade de Medicina, Portugal
2021/02/21 - 2021/03/04
Em curso
 Epidemiological surveillance (Outros)
Directorate-General of Health of Portugal, Portugal
2015/09 - 2020/06/12
Concluído
 Medicine (Mestrado integrado)
Faculdade de Medicina da Universidade do Porto, Portugal
"Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model" (TESE/DISSERTAÇÃO)
 15.145
2014/08 - 2018/09
Frequentou
 Nanomedicine for the treatment of tuberculosis (Pós-doutoramento)
Faculdade de Farmácia da Universidade do Porto, Portugal
2010/01/02 - 2013/12/11
Concluído
 European PhD in Pharmaceutical Sciences (Doutoramento)
Universidade do Porto Faculdade de Farmácia, Portugal
"Interactions of Rifabutin and novel analogs for tuberculosis with membranes: Implications for Mechanism of action and Drug Development" (TESE/DISSERTAÇÃO)
 Approved with unanimity and with distinction
2004/09 - 2009/11
Concluído
 Mestrado integrado em Ciências Farmacêuticas (Mestrado)
Universidade do Porto Faculdade de Farmácia, Portugal
"O papel do farmacêutico na gota. Final classification: 19 (0-20)" (TESE/DISSERTAÇÃO)
 16 valores (A)
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2018/11/01 - Atual Investigador (Investigação) Faculdade de Farmácia da Universidade do Porto, Portugal
2018/11/01 - 2024/03 Investigador Contratado (Investigação) REQUIMTE LAQV Porto, Portugal

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2022/01/01 - 2025/12/31 Interno (Médica) ARS Norte, Portugal
2021/01/04 - 2021/12/31 Interno (Médica) Centro Hospitalar Universitário do Porto EPE, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2020/03 - 2020/05 Team Leader of Medical Students in SNS24 during Covid-19 pandemic (volunteer) Sistema Nacional de Saúde, Portugal
2014/08/01 - 2018/10/31 Postdoctoral researcher in LAQV/REQUIMTE Universidade do Porto Faculdade de Farmácia, Portugal
2014/03/01 - 2014/07/31 Assistant Professor of Analytical Chemistry Universidade do Porto Faculdade de Farmácia, Portugal
Projetos

Bolsa

Designação Financiadores
2018 - 2021 Um pequeno par contra um grande trio
PTDC/BTM-SAL/29786/2017
 REQUIMTE
2013/04 - 2015/09 Y1 receptor based therapy for local bone repair: Antagonist behavior and delivery in challenged bone microenvironment
Provided by PTCRIS: 125869
Bolseiro de Investigação
Fundação para a Ciência e a Tecnologia
2012/03 - 2015/06 Antibody-directed liposomes for Alzheimer`s disease
Provided by PTCRIS: 118076
 Fundação para a Ciência e a Tecnologia

Projeto

Designação Financiadores
2019/06/04 - Atual Cardiovascular toxicity of NSAIDs: a role for membrane lipids?
2019023309
Investigador
CELLS ALBA Synchrotron, Espanha
2010 - Atual Researcher in Evaluation of novel antitubercular drugs on the biophysical properties of the membrane studied with 3D and 2D model systems
II-20100139 EC 2010-1012
Bolseiro de Investigação
HASYLAB at Deutsches Elektronen-Synchrotron DESY , Alemanha
Concluído
2018/01/07 - 2022/06/30 Principal Investigator (PI) of the project: “Nanomedicina como plataforma multifuncional para o tratamento de tuberculose sensível e multi-resistente a fármacos”.
POCI-01-0145-FEDER-030624 FEDER
Investigador responsável
Faculdade de Farmácia da Universidade do Porto, Portugal
Em curso
2020/07/01 - 2021/02/28 nano2Prevent: Nanoparticles to prevent SARS-CoV-2 transmission
ID 613531815
Investigador
Fundação para a Ciência e a Tecnologia, Portugal
Em curso
2013 - 2015 Unidade de Ciências Biomoleculares Aplicadas
UID/Multi/04378/2013
Investigador
REQUIMTE Unidade de Ciências Biomoleculares Aplicadas, Portugal
2012 - 2015 Researcher in Antibody-directed liposomes for Alzheimer's disease
PTDC/QUI-BIC/118076/2010
Bolseiro de Investigação
Concluído
2013 - 2013 Researcher in Evaluation of novel nonsteroidal anti-inflammatory drugs on the biophysical properties of the membrane studied 2D model systems
20130142
Investigador
Synchrotron SOLEIL, França
2007 - 2013 Nanoquímica
Norte 07- 0124 FEDER 000067
 Associação para a Inovação e Desenvolvimento da FCT
2011 - 2011 Researcher in Biophysical studies of cell penetrating peptides (CPP) on 3D and 2D membrane model systems
I-20110271 EC 2011-2012
Bolseiro de Investigação
HASYLAB at Deutsches Elektronen-Synchrotron DESY , Alemanha
Concluído
Produções

Publicações

Artigo em conferência
  1. Pinheiro, Marina; Carla Castro; Juan Casares; Marlene Lúcio; Marcela Segundo; Salette Reis; José Luís Costa Lima. "Study of antioxidants effect at the air-water interface: a biophysical approach to membrane peroxidation". Trabalho apresentado em FEBS Journal, Sevilha, 2012.
    Publicado
Artigo em jornal
  1. Pinheiro, Marina; David Nascimento Moreira; Ghidini, Michele. Autor correspondente: Ghidini, Michele. "Colon and rectal cancer: An emergent public health problem", World Journal of Gastroenterology, 2024, 7, https://www.wjgnet.com/1007-9327/full/v30/i7/644.htm.
  2. Pinheiro, Marina; João Rocha Neves. Autor correspondente: Pinheiro, Marina. "R2CHA2DS2-VA predicts the cardiovascular risk after carotid endarterectomy", Ann Vasc Surg. , 2023
    10.1016/j.avsg.2023.02.016
  3. Farabegoli, Fulvia; Andreia Granja; Joana Magalhães; Stefania Purgato; Manuela Voltattorni; Pinheiro, Marina. Autor correspondente: Farabegoli, Fulvia. "Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines", ACS Omega, 2022
    10.1021/acsomega.2c01829
  4. Ana Joyce Coutinho; Marina Pinheiro; Ana Rute Neves; Madalena M. M. Pinto. Autor correspondente: Ana Rute Neves. "Therapeutic potential of genistein: preclinical studies, clinical evidence, and nanotechnology application", Curr Med Chem , 2022, https://pubmed.ncbi.nlm.nih.gov/36200214/.
    10.2174/0929867329666221004124800
Artigo em revista
  1. Pinheiro, Marina; Silva, Sílvia; Lemos, Marta; Barros, Lucinda; Zambrano, Rosa; Brito, Edite; Fonseca, Ana; Nascimento, David. "Sociodemographic characterization and access to health services in the gypsy community of Barcelos, Portugal". Population Medicine 5 Supplement (2023): http://dx.doi.org/10.18332/popmed/164679.
    10.18332/popmed/164679
  2. Behzadi, Payam; García-Perdomo, Herney Andrés; Autrán Gómez, Ana Maria; Pinheiro, Marina; Sarshar, Meysam. "Editorial: Uropathogens, urinary tract infections, the host-pathogen interactions and treatment". Frontiers in Microbiology 14 (2023): http://dx.doi.org/10.3389/fmicb.2023.1183236.
    10.3389/fmicb.2023.1183236
  3. Marina Pinheiro; Sandra G. Silva. "Special Issue on Drug–Membrane Interactions Volume II". Membranes (2022): https://doi.org/10.3390/membranes12101018.
    10.3390/membranes12101018
  4. Silva, Sandra G.; Pinheiro, Marina; Pereira, Rui; Dias, Ana Rita; Ferraz, Ricardo; Prudêncio, Cristina; Eaton, Peter J.; Reis, Salette; do Vale, M. Luísa C.. Autor correspondente: do Vale, M. Luísa C.. "Serine-based surfactants as effective antimicrobial agents against multiresistant bacteria". Biochimica et Biophysica Acta (BBA) - Biomembranes 1864 9 (2022): 183969. http://dx.doi.org/10.1016/j.bbamem.2022.183969.
    10.1016/j.bbamem.2022.183969
  5. Ghidini, Michele; Silva, Sandra G.; Evangelista, Jessica; do Vale, Maria Luísa C.; Farooqi, Ammad Ahmad; Pinheiro, Marina. "Nanomedicine for the Delivery of RNA in Cancer". Cancers 14 11 (2022): 2677. http://dx.doi.org/10.3390/cancers14112677.
    10.3390/cancers14112677
  6. Farabegoli, Fulvia; Pinheiro, Marina. "Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy". Frontiers in Pharmacology 13 (2022): http://dx.doi.org/10.3389/fphar.2022.809706.
    10.3389/fphar.2022.809706
  7. Behzadi, Payam; Sameer, Aga Syed; Nissar, Saniya; Banday, Mujeeb Zafar; Gajdács, Márió; García-Perdomo, Herney Andrés; Akhtar, Kulsum; et al. "The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs)". Journal of Immunology Research 2022 (2022): 1-25. http://dx.doi.org/10.1155/2022/2054431.
    10.1155/2022/2054431
  8. "Management of the upper limb arteriovenous malformations". Portuguese Journal of Cardiac Thoracic and Vascular Surgery (2022):
    Aceite para publicação
  9. Nichols, Emma; Steinmetz, Jaimie D; Vollset, Stein Emil; Fukutaki, Kai; Chalek, Julian; Abd-Allah, Foad; Abdoli, Amir; et al. "Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019". The Lancet Public Health 7 2 (2022): e105-e125. http://dx.doi.org/10.1016/s2468-2667(21)00249-8.
    10.1016/s2468-2667(21)00249-8
  10. Rúben G. R. Pinheiro; Ana Joyce Coutinho; Marina Pinheiro; Ana Rute Neves. "Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?". International Journal of Molecular Sciences (2021): https://doi.org/10.3390/ijms222111654.
    10.3390/ijms222111654
  11. Sean Saramago; Joana Magalhães; Marina Pinheiro. Autor correspondente: Joana Magalhães. "Tuberculosis Vaccines: An Update of Recent and Ongoing Clinical Trials". Applied Sciences 11 19 (2021): 9250-9250. https://doi.org/10.3390/app11199250.
    10.3390/app11199250
  12. Marina Pinheiro. Autor correspondente: Marina Pinheiro. "Special Issue on Drug–Membrane Interactions". Membranes (2021): https://www.mdpi.com/2077-0375/11/10/764.
    10.3390/membranes11100764
  13. Granja, Andreia; Lima-Sousa, Rita; Alves, Cátia G.; de Melo-Diogo, Duarte; Pinheiro, Marina; Sousa, Célia T.; Correia, Ilídio J.; Reis, Salette. "Mitoxantrone-loaded lipid nanoparticles for breast cancer therapy – Quality-by-design approach and efficacy assessment in 2D and 3D in vitro cancer models". International Journal of Pharmaceutics 607 (2021): 121044. http://dx.doi.org/10.1016/j.ijpharm.2021.121044.
    10.1016/j.ijpharm.2021.121044
  14. Granja, Andreia; Pinheiro, Marina; Sousa, Célia T.; Reis, Salette. "Gold nanostructures as mediators of hyperthermia therapies in breast cancer". Biochemical Pharmacology 190 (2021): 114639. http://dx.doi.org/10.1016/j.bcp.2021.114639.
    10.1016/j.bcp.2021.114639
  15. Rui Pereira; Sandra G. Silva; Marina Pinheiro; Salette Reis; M. Luísa do Vale. "Current Status of Amino Acid-Based Permeation Enhancers in Transdermal Drug Delivery". Membranes 11 5 (2021): 343-343. https://doi.org/10.3390/membranes11050343.
    10.3390/membranes11050343
  16. Moreira, Rita; Granja, Andreia; Pinheiro, Marina; Reis, Salette. Autor correspondente: Pinheiro, Marina. "Nanomedicine Interventions in Clinical Trials for the Treatment of Metastatic Breast Cancer". Applied Sciences 11 4 (2021): 1624. http://dx.doi.org/10.3390/app11041624.
    Publicado • 10.3390/app11041624
  17. Adelson, Jaimie D; Bourne, Rupert R A; Briant, Paul Svitil; Flaxman, Seth R; Taylor, Hugh R B; Jonas, Jost B; Abdoli, Amir Aberhe; et al. "Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study". The Lancet Global Health 9 2 (2021): e144-e160. http://dx.doi.org/10.1016/s2214-109x(20)30489-7.
    10.1016/s2214-109x(20)30489-7
  18. Vieira, Alexandre C.C.; Chaves, Luíse L.; Pinheiro, Marina; Lima, Sofia Costa; Neto, Pedro José Rolim; Ferreira, Domingos; Sarmento, Bruno; Reis, Salette. "Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages". Carbohydrate Polymers 252 (2021): 116978. http://dx.doi.org/10.1016/j.carbpol.2020.116978.
    Publicado • 10.1016/j.carbpol.2020.116978
  19. Pinheiro, Marina. "Transferrin-functionalized lipid nanoparticles for curcumin brain delivery". Journal of Biotechnology (2021):
    Em revisão
  20. Aguiar, Luísa; Pinheiro, Marina; Neves, Ana Rute; Vale, Nuno; Defaus, Sira; Andreu, David; Reis, Salette; Gomes, Paula. "Insights into the Membranolytic Activity of Antimalarial Drug-Cell Penetrating Peptide Conjugates". Membranes 11 1 (2020): 4. http://dx.doi.org/10.3390/membranes11010004.
    Publicado • 10.3390/membranes11010004
  21. Murray, Christopher J L; Abbafati, Cristiana; Abbas, Kaja M; Abbasi, Mohammad; Abbasi-Kangevari, Mohsen; Abd-Allah, Foad; Abdollahi, Mohammad; et al. "Five insights from the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1135-1159. http://dx.doi.org/10.1016/s0140-6736(20)31404-5.
    10.1016/s0140-6736(20)31404-5
  22. Pinheiro, R.G.R.; Granja, A.; Loureiro, J.A.; Pereira, M.C.; Pinheiro, M.; Neves, A.R.; Reis, S.. "RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer’s Disease". Pharmaceutical Research 37 7 (2020): http://dx.doi.org/10.1007/s11095-020-02865-1.
    Publicado • 10.1007/s11095-020-02865-1
  23. Pinheiro, R.G.R; Granja, A; Loureiro, J.A; Pereira, M.C; Pinheiro, M; Neves, A.R; Reis, S. "Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease". European Journal of Pharmaceutical Sciences 148 (2020): 105314. http://dx.doi.org/10.1016/j.ejps.2020.105314.
    10.1016/j.ejps.2020.105314
  24. Pinheiro, Marina; James, S.L.; Castle, C.D.; Dingels, Z.V.; Fox, J.T.; Hamilton, E.B.; Liu, Z.; et al. "Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017". Injury Prevention 26 1 (2020): 96-114https://injurypre. https://injuryprevention.bmj.com/content/26/Supp_1/i96.long.
    Publicado • 10.1136/injuryprev-2019-043494
  25. Farooqi, Ammad Ahmad; Pinheiro, Marina; Granja, Andreia; Farabegoli, Fulvia; Reis, Salette; Attar, Rukset; Sabitaliyevich, Uteuliyev Yerzhan; Xu, Baojun; Ahmad, Aamir. "EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/ß-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways". Cancers 12 4 (2020): 951. http://dx.doi.org/10.3390/cancers12040951.
    10.3390/cancers12040951
  26. Magalhães, Joana; Pinheiro, Marina; Drasler, Barbara; Septiadi, Dedy; Petri-Fink, Alke; Santos, Susana G; Rothen-Rutishauser, Barbara; Reis, Salette. Autor correspondente: Reis, Salette. "Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model". Nanomedicine 15 3 (2020): 259-271. http://dx.doi.org/10.2217/nnm-2019-0256.
    10.2217/nnm-2019-0256
  27. Magalhães, Joana; L. Chaves, Luise; C. Vieira, Alexandre; G. Santos, Susana; Pinheiro, Marina; Reis, Salette. "Optimization of Rifapentine-Loaded Lipid Nanoparticles Using a Quality-by-Design Strategy". Pharmaceutics 12 1 (2020): 75. http://dx.doi.org/10.3390/pharmaceutics12010075.
    10.3390/pharmaceutics12010075
  28. Abbafati, C.; Machado, D.B.; Cislaghi, B.; Salman, O.M.; Karanikolos, M.; McKee, M.; Abbas, K.M.; et al. "Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1223-1249. http://www.scopus.com/inward/record.url?eid=2-s2.0-85092451099&partnerID=MN8TOARS.
    10.1016/S0140-6736(20)30752-2
  29. Abbafati, C.; Machado, D.B.; Cislaghi, B.; Salman, O.M.; Karanikolos, M.; McKee, M.; Abbas, K.M.; et al. "Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1160-1203. http://www.scopus.com/inward/record.url?eid=2-s2.0-85092447915&partnerID=MN8TOARS.
    10.1016/S0140-6736(20)30977-6
  30. Lozano, R.; Fullman, N.; Mumford, J.E.; Knight, M.; Barthelemy, C.M.; Abbafati, C.; Abbastabar, H.; et al. "Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1250-1284. http://www.scopus.com/inward/record.url?eid=2-s2.0-85090485900&partnerID=MN8TOARS.
    10.1016/S0140-6736(20)30750-9
  31. Abbafati, C.; Machado, D.B.; Cislaghi, B.; Salman, O.M.; Karanikolos, M.; McKee, M.; Abbas, K.M.; et al. "Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019". The Lancet 396 10258 (2020): 1204-1222. http://www.scopus.com/inward/record.url?eid=2-s2.0-85092481765&partnerID=MN8TOARS.
    10.1016/S0140-6736(20)30925-9
  32. Marina Pinheiro; Heinz Amenitsch; Salette Reis. "Antituberculosis Drug Interactions with Membranes: A Biophysical Approach Applied to Bedaquiline". Membranes (2019): https://doi.org/10.3390/membranes9110141.
    10.3390/membranes9110141
  33. Pinheiro, Marina; Magalhães, Joana; Reis, Salette. "Antibiotic interactions using liposomes as model lipid membranes". Chemistry and Physics of Lipids (2019): http://dx.doi.org/10.1016/j.chemphyslip.2019.05.002.
    10.1016/j.chemphyslip.2019.05.002
  34. Granja, A.; Neves, A.R.; Sousa, C.T.; Pinheiro, M.; Reis, S.. "EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers". Heliyon 5 7 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85068239916&partnerID=MN8TOARS.
    10.1016/j.heliyon.2019.e02020
  35. Alexandre C. C. Vieira; Luíse L. Chaves; Marina Pinheiro; Sofia A. Costa Lima; Domingos Ferreira; Bruno Sarmento; Salette Reis. "Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages". Artificial Cells, Nanomedicine, and Biotechnology (2018): 1-11. https://doi.org/10.1080/21691401.2018.1434186.
    10.1080/21691401.2018.1434186
  36. Lage, E.V.; Magalhães, J.; Pinheiro, M.; Reis, S.. "Effect of the alkyl group in the piperazine N-substitution on the therapeutic action of rifamycins: A drug-membrane interaction study". Chemico-Biological Interactions 289 (2018): 75-80. http://www.scopus.com/inward/record.url?eid=2-s2.0-85046753122&partnerID=MN8TOARS.
    10.1016/j.cbi.2018.04.027
  37. Morais, C.M.; Cardoso, A.M.; Cunha, P.P.; Aguiar, L.; Vale, N.; Lage, E.; Pinheiro, M.; et al. "Acylation of the S413-PV cell-penetrating peptide as a means of enhancing its capacity to mediate nucleic acid delivery: Relevance of peptide/lipid interactions". Biochimica et Biophysica Acta - Biomembranes 1860 12 (2018): 2619-2634. http://www.scopus.com/inward/record.url?eid=2-s2.0-85054439165&partnerID=MN8TOARS.
    10.1016/j.bbamem.2018.10.002
  38. Vieira, A.C.C.; Chaves, L.L.; Pinheiro, S.; Pinto, S.; Pinheiro, M.; Lima, S.C.; Ferreira, D.; Sarmento, B.; Reis, S.. "Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis". International Journal of Pharmaceutics 536 1 (2018): 478-485. http://www.scopus.com/inward/record.url?eid=2-s2.0-85037993500&partnerID=MN8TOARS.
    10.1016/j.ijpharm.2017.11.071
  39. Pinheiro, Marina; Alexandre Vieira; Joana Magalhães; Sónia Rocha; Marcos Cardoso; Margarida Borges; Salette Reis. "Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.". Nanomedicine (London, England) 12 24 (2017): 2721-2736. http://europepmc.org/abstract/med/29119867.
    10.2217/nnm-2017-0248
  40. Pinheiro, Marina; Ricardo Ferraz; Ana Gomes; Cátia Teixeira; Cristina Prudêncio; Salette Reis; Paula Gomes. "Effects of novel triple-stage antimalarial ionic liquids on lipid membrane models.". Bioorganic & medicinal chemistry letters (2017): http://europepmc.org/abstract/med/28733082.
    10.1016/j.bmcl.2017.07.006
  41. Pinheiro, Marina; Lilia Ulanova; Carina Vibe; Claudia Nunes; Dorna Misaghian; Steven Wilson; Kaizheng Zhu; et al. "Treatment of Francisella infections via PLGA- and lipid-based nanoparticle delivery of antibiotics in a zebrafish model.". Diseases of aquatic organisms (2017): http://europepmc.org/abstract/med/28627489.
    10.3354/dao03129
  42. Granja, A.; Frias, I.; Neves, A.R.; Pinheiro, M. (corresponding author); Reis, S.. "Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems". BioMed Research International 2017 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85027178920&partnerID=MN8TOARS.
    10.1155/2017/5813793
  43. Costa A; Pinheiro M; Magalhães J; Ribeiro R; Seabra V; Reis S; Sarmento B. "The formulation of nanomedicines for treating tuberculosis.". Advanced Drug Delivery Reviews (2016): http://europepmc.org/abstract/med/27108703.
    10.1016/j.addr.2016.04.012
  44. Vieira, A. C.; Chaves, L. L.; Pinheiro, M.; Ferreira, D.; Sarmento, B.; Reis, S.. "Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells". Int J Nanomedicine 11 (2016): 2601-17.
    10.2147/IJN.S104908
  45. Granja A; Pinheiro M (corresponding author); Reis S. "Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.". Nutrients 8 5 (2016): 307. http://europepmc.org/abstract/med/27213442.
    Acesso aberto • 10.3390/nu8050307
  46. Frias, I.; Neves, A.R.; Pinheiro, M. (corresponding author); Reis, S.. "Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation". Drug Design, Development and Therapy 10 (2016): 3319-3528. http://www.scopus.com/inward/record.url?eid=2-s2.0-84994474541&partnerID=MN8TOARS.
    10.2147/DDDT.S109589
  47. Pinheiro, M.; Ribeiro, R.; Vieira, A.; Andrade, F.; Reis, S.. "Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis". Drug Design, Development and Therapy 10 (2016): 2467-2475. http://www.scopus.com/inward/record.url?eid=2-s2.0-84983285068&partnerID=MN8TOARS.
    10.2147/DDDT.S104395
  48. Monteiro, C.; Pinheiro, M.; Fernandes, M.; Maia, S.; Seabra, C.L.; Ferreira-Da-Silva, F.; Reis, S.; Gomes, P.; Martins, M.C.L.. "A 17-mer Membrane-Active MSI-78 Derivative with Improved Selectivity toward Bacterial Cells". Molecular Pharmaceutics 12 8 (2015): 2904-2911. http://www.scopus.com/inward/record.url?eid=2-s2.0-84938303316&partnerID=MN8TOARS.
    10.1021/acs.molpharmaceut.5b00113
  49. Monteiro, C.; Fernandes, M.; Pinheiro, M.; Maia, S.; Seabra, C.L.; Ferreira-Da-Silva, F.; Costa, F.; et al. "Antimicrobial properties of membrane-active dodecapeptides derived from MSI-78". Biochimica et Biophysica Acta - Biomembranes 1848 5 (2015): 1139-1146. http://www.scopus.com/inward/record.url?eid=2-s2.0-84923289681&partnerID=MN8TOARS.
    10.1016/j.bbamem.2015.02.001
  50. Pinheiro, M. (corresponding author); Silva, A.S.; Reis, S.. "Molecular interactions of rifabutin with membrane under acidic conditions". International Journal of Pharmaceutics 479 1 (2015): 63-69. http://www.scopus.com/inward/record.url?eid=2-s2.0-84920115659&partnerID=MN8TOARS.
    10.1016/j.ijpharm.2014.12.042
  51. Pinheiro, M. (corresponding author); Silva, A.S.; Pisco, S.; Reis, S.. "Interactions of isoniazid with membrane models: Implications for drug mechanism of action". Chemistry and Physics of Lipids 183 (2014): 184-190. http://www.scopus.com/inward/record.url?eid=2-s2.0-84904864053&partnerID=MN8TOARS.
    10.1016/j.chemphyslip.2014.07.002
  52. Pinheiro, M. (corresponding author); Pisco, S.; Silva, A.S.; Nunes, C.; Reis, S.. "Evaluation of the effect of rifampicin on the biophysical properties of the membranes: Significance for therapeutic and side effects". International Journal of Pharmaceutics 466 1-2 (2014): 190-197. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897056385&partnerID=MN8TOARS.
    10.1016/j.ijpharm.2014.03.005
  53. Castro, C.M.; Pinheiro, M.; Lúcio, M.; Giner-Casares, J.J.; Camacho, L.; Lima, J.L.F.C.; Reis, S.; Segundo, M.A.. "Insights about a-tocopherol and Trolox interaction with phosphatidylcholine monolayers under peroxidation conditions through Brewster angle microscopy". Colloids and Surfaces B: Biointerfaces 111 (2013): 626-635. http://www.scopus.com/inward/record.url?eid=2-s2.0-84881224703&partnerID=MN8TOARS.
    10.1016/j.colsurfb.2013.06.043
  54. Pinheiro, M.; Giner-Casares, J.J.; Lúcio, M.; Caio, J.M.; Moiteiro, C.; Lima, J.L.F.C.; Reis, S.; Camacho, L.. "Interplay of mycolic acids, antimycobacterial compounds and pulmonary surfactant membrane: A biophysical approach to disease". Biochimica et Biophysica Acta - Biomembranes 1828 2 (2013): 896-905. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871760173&partnerID=MN8TOARS.
    10.1016/j.bbamem.2012.09.015
  55. Pinheiro, M.; Areîde, M.; Nunes, C.; Caio, J.M.; Moiteiro, C.; Lúcio, M.; Reis, S.. "Differential interactions of rifabutin with human and bacterial membranes: Implication for its therapeutic and toxic effects". Journal of Medicinal Chemistry 56 2 (2013): 417-426. http://www.scopus.com/inward/record.url?eid=2-s2.0-84872762090&partnerID=MN8TOARS.
    10.1021/jm301116j
  56. Pinheiro, M.; Arêde, M.; Giner-Casares, J.J.; Nunes, C.; Caio, J.M.; Moiteiro, C.; Lúcio, M.; Camacho, L.; Reis, S.. "Effects of a novel antimycobacterial compound on the biophysical properties of a pulmonary surfactant model membrane". International Journal of Pharmaceutics 450 1-2 (2013): 268-277. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878374659&partnerID=MN8TOARS.
    10.1016/j.ijpharm.2013.03.062
  57. Pinheiro, M.; Nunes, C.; Caio, J.M.; Moiteiro, C.; Lúcio, M.; Brezesinski, G.; Reis, S.. "The influence of Rifabutin on human and bacterial membrane models: Implications for its mechanism of action". Journal of Physical Chemistry B 117 20 (2013): 6187-6193. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878076350&partnerID=MN8TOARS.
    10.1021/jp403073v
  58. Nunes, C.; Lopes, D.; Pinheiro, M.; Pereira-Leite, C.; Reis, S.. "In vitro assessment of NSAIDs-membrane interactions: Significance for pharmacological actions". Pharmaceutical Research 30 8 (2013): 2097-2107. http://www.scopus.com/inward/record.url?eid=2-s2.0-84879796026&partnerID=MN8TOARS.
    10.1007/s11095-013-1066-8
  59. Pinheiro, M.; Nunes, C.; Caio, J.M.; Moiteiro, C.; Brezesinski, G.; Reis, S.. "Interactions of N'-acetyl-rifabutin and N'-butanoyl-rifabutin with lipid bilayers: A synchrotron X-ray study". International Journal of Pharmaceutics 453 2 (2013): 560-568. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884157765&partnerID=MN8TOARS.
    10.1016/j.ijpharm.2013.06.018
  60. Pinheiro, M.; Arêde, M.; Caio, J.M.; Moiteiro, C.; Lúcio, M.; Reis, S.. "Drug-membrane interaction studies applied to N'-acetyl-rifabutin". European Journal of Pharmaceutics and Biopharmaceutics 85 3 PART A (2013): 597-603. http://www.scopus.com/inward/record.url?eid=2-s2.0-84888359004&partnerID=MN8TOARS.
    10.1016/j.ejpb.2013.02.015
  61. Pinheiro, M.; Pereira-Leite, C.; Arêde, M.; Nunes, C.; Caio, J.M.; Moiteiro, C.; Giner-Casares, J.J.; et al. "Evaluation of the structure-activity relationship of rifabutin and analogs: A drug-membrane study". ChemPhysChem 14 12 (2013): 2808-2816. http://www.scopus.com/inward/record.url?eid=2-s2.0-84882585940&partnerID=MN8TOARS.
    10.1002/cphc.201300262
  62. Pinheiro, M.; Lúcio, M.; Reis, S.; Lima, J.L.F.C.; Caio, J.M.; Moiteiro, C.; Martín-Romero, M.T.; Camacho, L.; Giner-Casares, J.J.. "Molecular interaction of Rifabutin on model lung surfactant monolayers". Journal of Physical Chemistry B 116 38 (2012): 11635-11645. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866875771&partnerID=MN8TOARS.
    10.1021/jp303725j
  63. Pinheiro, M.; Lcio, M.; LiM.A., J.L.F.C.; Reis, S.. "Liposomes as drug delivery systems for the treatment of TB". Nanomedicine 6 8 (2011): 1413-1428. http://www.scopus.com/inward/record.url?eid=2-s2.0-80155125245&partnerID=MN8TOARS.
    10.2217/nnm.11.122
Capítulo de livro
  1. Pinheiro, Marina (corresponding author); Joana Magalhães; Alexandre Vieira; Soraia Pinto; Sara Pinheiro; Andreia Granja; Susana Santos; Salette Reis. "New approaches from nanomedicine and pulmonary drug delivery for the treatment of Tuberculosis". In Nanoparticles in the Life Sciences and Biomedicine. Pan Stanford Publishing, 2018.
    Publicado
  2. Pinheiro, Marina (corresponding author); Joana Magalhães; Alexandre Vieira; Susana Santos; Salette Reis. "Nanostructures For Tuberculosis Disease Treatment". In Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics, 1-372. Elsevier, 2017.
Poster em conferência
  1. Hugo Silva; Pinheiro, Marina; David N Moreira; FIRMINO, JOÃO. "Construção e aplicação de uma escala piloto para avaliar o bem-estar e qualidade de vida". Trabalho apresentado em Encontro Nacional de Médicos Internos de Saúde Pública, 2023.
  2. Lúcia Santos; Sandra Silva; Pinheiro, Marina. Autor correspondente: Pinheiro, Marina. "Passive targeting drug delivery to macrophages using lipid nanoparticles for the treatment of infectious diseases". Trabalho apresentado em MEEting 2023, 2023.
  3. Pinheiro, Marina; Marta Lemos; Maria Amorim; David Nascimento. Autor correspondente: Pinheiro, Marina. "Cancro do cólon e reto: um problema de Saúde Pública". Trabalho apresentado em Congresso Nacional da Unidade de Saúde do ACES Baixo Vouga, 2022.
  4. Marina Pinheiro; Lucinda Barros; Maria Amorim; Edite Brito; Ana Fonseca; Sílvia Silva; Marta Lemos; David Nascimento. "Caraterização sociodemográfica, acesso e resultados em saúde de uma comunidade cigana de Barcelos em 2021". Trabalho apresentado em Congresso Nacional da Unidade de Saúde do ACES Baixo Vouga, 2022.
  5. Marta Lemos; David Nascimento; Marina Mesquita; Pinheiro, Marina; Adérito Gomes; Maria Pereira; Maria Amorim. "Impacte da pandemia COVID-19 no cumprimento do PNV no ACES Cávado III – Barcelos/Esposende". Trabalho apresentado em Congresso Nacional da Unidade de Saúde do ACES Baixo Vouga, 2022.
  6. Maria Conceição Pito; Pinheiro, Marina; Joana Magalhães; Nóbrega, Clévio David Rodrigues. "Lipid Nanoparticles as Drug Delivery Systems of Rifampicin for the Treatment of Tuberculosis". Trabalho apresentado em MEEting 2022, 2022.
  7. Joana Magalhães; Pinheiro, Marina; Salette Reis; Magalhães, Joana; Pinheiro, Marina; Drasler, Barbara; Septiadi, Dedy; et al. "Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model". Trabalho apresentado em 2º Simpósio de Investigação em Tuberculose e Micobactérias Não Tuberculosas, 2020.
    10.2217/nnm-2019-0256
  8. Pinheiro, Marina. "Optimization of lipid nanoparticles for tuberculosis therapy based on a quality-by-design strategy". Trabalho apresentado em 2º Simpósio de Investigação em Tuberculose e Micobactérias Não Tuberculosas, 2020.
  9. Salette Reis; Joana Magalhães; Pinheiro, Marina. "Targeted delivery of rifampicin-loaded lipid nanoparticles for tuberculosis treatment". Trabalho apresentado em 2º Simpósio de Investigação em Tuberculose e Micobactérias Não Tuberculosas, 2020.
  10. Pinheiro, Marina. "Lapatinib-loaded nanostructured lipid carriers for breast cancer therapy". Trabalho apresentado em XXV Encontro Luso-Galego de Química, Santiago de Compostela, 2019.
  11. Pinheiro, Marina. "Biocompatible and macrophage-targeting of mannosylated lipid nanoparticles for tuberculosis treatment". Trabalho apresentado em XXV Encontro Luso-Galego de Química, Santiago de Compostela, 2019.
  12. Pinheiro, Marina. "Serine-based surfactants: potential drug and antimicrobial agents". Trabalho apresentado em XXV Encontro Luso-Galego de Química, 2019.
  13. Pinheiro, Marina. "Assessing the influence of gold nanoparticles in photodynamic therapy using singlet oxygen sensitizers". Trabalho apresentado em BioBrillouin Meeting, 2019.
  14. Pinheiro, Marina. "Nanomedicine for breast cancer therapy: lipid nanoparticles as targeted drug delivery systems". Trabalho apresentado em 17th International Nanomedicine & Drug Delivery Symposium (nanoDDS’2019), 2019.
  15. Pinheiro, Marina. "Management of the upper limb arteriovenous malformations". Trabalho apresentado em Porto Vacular Conference, 2019.
  16. Pinheiro, Marina; Paula, Pinto; Reis, Salette. "Development of Lipid Nanoparticles as Drug Delivery Systems against Tuberculosis". Trabalho apresentado em 5º MEEting do MIM, 2019.
  17. Pinheiro, Marina. "Nanomedicine for the treatment of breast cancer: drug delivery of lapatinib using nanostructured lipid carriers". Trabalho apresentado em 5º MEEting do MIM, 2019.
  18. Pinheiro, Marina. "Lipid nanoparticles as drug delivery vehicles for breast cancer therapy". Trabalho apresentado em Advanced spectroscopic analytical methods and new technologies in drug delivery, 2019.
  19. Andreia Granja; Pinheiro, Marina; Célia Sousa; Salette Reis. "Advanced spectroscopic analytical methods and new technologies in drug delivery". Trabalho apresentado em COST action “CA16205 - European Network on Understanding Gastrointestinal Absorption-related Processes”, Helsinki, Finland, 2019.
  20. Pinheiro, Marina; Pinto, Soraia; Pinheiro, Soraia; Vieira, Alexandre; Magalhães, Joana; Reis, Salette. "Nanostructured lipid carriers as a versatil oral delivery vehicle of rifampicin". Trabalho apresentado em ACS Publications Symposium, Innovation in Materials Science, 2018.
  21. Pinheiro, Marina; Pinto, Soraia; Pinheiro, Sara; Magalhães, Joana; Reis, Salette. "Nanostructured lipid carriers as a versatil oral delivery vehicle of streptomycin". Trabalho apresentado em 9th Meeting of the Analytical Chemistry Division: Analítica, 2018.
  22. Pinheiro, Marina; Pinto, Soraia; Pinheiro, Sara; Magalhães, Joana; Vieira, Alexandre; Reis, Salette. "Nanostructured lipid carriers (NLCs) as a promising drug delivery system for streptomycin delivery". Trabalho apresentado em IJUP – Encontro Investigação Jovem da Universidade do Porto., 2018.
  23. Pinheiro, Marina; Granja, Andreia; Viera, Alexandre; Lopes, Luíse; Sousa, Célia; Reis, Salette; Pinheiro, Marina (corresponding author); et al. "Folate-targeted nanostructured lipid carriers for enhanced oral delivery of Epigallocatechin-3-gallate". Trabalho apresentado em Brillouin Microscopy: Emerging Tool for Probing Mechanical Properties of Living Cells, 2018.
    10.1016/j.foodchem.2017.06.019
  24. Pinheiro, Marina; Alves, Marisa; Nunes, Claudia; Reis, Salette. "Interacção fármaco-membrana da rifapentina". Trabalho apresentado em 4º MEEting do MIM, 2018.
  25. Pinheiro, Marina; Alpoim, Daniela; Nunes, Claudia; Reis, Salette. "Molecular interactions of epigallocatechin gallate with lipid membrane models". Trabalho apresentado em Molecular interactions of epigallocatechin gallate with lipid membrane models, 2018.
  26. Pinheiro, Marina; Magalhães, Joana; Viera, Alexandre; Rocha, Sónia; Cardoso, Marcos; Santos, Susana; Borges, Margarida; Reis, Salette. "Rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment: an active targeting approach". Trabalho apresentado em NanoBio&Med2017, 2017.
  27. Pinheiro, Marina; Ferraz, Ricardo; Teixeira, C; Gomes, A; Prudêncio, C; Reis, S; Gomes, P. "Novel triple-stage antimalarial ionic liquids and their effects on lipid membrane models". Trabalho apresentado em Encontro Nacional da Sociedade Portuguesa de Química, 2017.
  28. Pinheiro, Marina; Pinto, Soraia; Pinheiro, Sara; Vieira, Alexandre; Magalhães, Joana; Reis, Salette. "Nanostructured lipid carriers as a promising drug delivery system for streptomycin". Trabalho apresentado em IJUP – Encontro Investigação Jovem da Universidade do Porto, 2017.
  29. Pinheiro, Marina; Pinheiro, Sara; Viera, Alexandre; Luíse, Lopes; Domingos, Ferreira; Sarmento, Bruno; Reis, Salette. "Development of innovative lipid nanoparticles for the treatment of tuberculosis". Trabalho apresentado em IJUP – Encontro Investigação Jovem da Universidade do Porto. Porto, 2017.
  30. Pinheiro, Marina; Morais, C; Cunha, P; Cardoso, A; Aguiar, L.; Vale, N; Lage, E; et al. "Membrane perturbations induced by acylated S413-PV analogs: relevance to nucleic acid delivery". Trabalho apresentado em 34th European Peptide Symposium, 2016.
  31. Pinheiro, Marina; Pinheiro, Sara; Pinto, Soraia; Magalhães, Joana; Viera, Alexandre; Reis, Salette. "Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis". Trabalho apresentado em 252nd American Chemical Society National Meeting & Exposition, 2016.
  32. Pinheiro, Marina; Lage, Emílio; Reis, Salette. "Physicochemical approach to the therapeutic activity of anti-tuberculosis drugs: interaction with biomembranes". Trabalho apresentado em 25PYCHEM 1EYCHEM, 2016.
  33. Pinheiro, Marina; Magalhães, Joana; Vieira, Alexandre; Lopes, Luíse; Borges, Margarida; Santos, Susana; Reis, Salette. "Nanostructured lipid carriers as drug delivery systems of rifapentine: a tool to overcome the drawbacks of tuberculosis oral therapy". Trabalho apresentado em 7th International Congress on Nanotechnology in Biology & Medicine, 2016.
  34. Pinheiro, Marina; Vieira, Alexandre; Chaves, Luíse; Domingos, Ferreira; Sarmento, Bruno; Reis, Salette. "Design and statistical modeling of mannose-decorated dapsone-lipid nanoparticles as a strategy to targeting M-cells by oral route". Trabalho apresentado em Bionanomed. Krems, 2016.
  35. Pinheiro, Marina; Pinto, Soraia; Pinheiro, Sara; Vieira, Alexandre; Magalhães, Joana; Reis, Salette. "Nanostructured lipid carriers loaded with rifapentine: a drug delivery system for pulmonary tuberculosis". Trabalho apresentado em IJUP – Encontro Investigação Jovem da Universidade do Porto, 2016.
  36. Pinheiro, Marina; Pinheiro, Sara; Pinto, Soraia; Magalhães, Joana; Vieira, Alexandre; Ferreira, Domingos; Sarmento, Bruno; Reis, Salette. "Solid lipid nanoparticles for specific delivery of rifampicin to alveolar macrophages". Trabalho apresentado em IJUP – Encontro Investigação Jovem da Universidade do Porto, 2016.
  37. Pinheiro, Marina; Granja, Andreia; Viera, Alexandre; Nunes, Claudia; Reis, Salette. "Targeted nanostructured lipid carriers based epigallocatechin gallate delivery system to cancer cells". Trabalho apresentado em IJUP – Encontro Investigação Jovem da Universidade do Porto, 2016.
  38. Pinheiro, Marina; Vieira, Alexandre; Lopes, Luíse; Ferreira, Domingos; Sarmento, Bruno; Reis, Salette. "Application of experimental design as optimization strategy in the development of nanoparticles as drug delivery systems for poorly soluble drugs as dapsone". Trabalho apresentado em Encontro Galego Português de Química, 2015.
  39. Pinheiro, Marina; Vieira, Alexandre; Lopes, Luíse; Ferreira, Domingos; Sarmento, Bruno; Reis, Salette. "Dual Site-Specific and Ph-Sensitive Drug Delivery System for the Improvement of the Pulmonary Tubercolosis Treatment". Trabalho apresentado em AAPS Annual Meeting and Exposition, 2015.
  40. Pinheiro, Marina; Vieira, Alexandre; Lopes, Luíse; Ferreira, Domingos; Sarmento, Bruno; Reis, Salette. "Development of solid lipid nanoparticles of dapsone as a novel drug release system against mycobacterium leprae". Trabalho apresentado em XXIV Encontro Nacional da Sociedade Portuguesa de Química, 2015.
  41. Pinheiro, Marina; Magalhães, Joana; Vieira, Alexandre; Reis, Salette. "Nanostructured lipid carriers as drug delivery systems of rifapentine to simplified the treatment of pulmonary tuberculosis". Trabalho apresentado em Advanced Summer School - The Nano/medicine interface, 2015.
  42. Pinheiro, Marina; Vieira, Alexandre; Lopes, Luíse; Ferreira, Domingos; Sarmento, Bruno; Reis, Salette. "Application of drug delivery systems for treatment of pulmonary tuberculosis". Trabalho apresentado em Bio Engineering Conference’14, 2014.
  43. Pinheiro, Marina; Iuri, Frias; Reis, Salette. "Development of lipid nanocarrier-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation". Trabalho apresentado em XX Encontro Luso Galego de Química, 2014.
  44. Pinheiro, Marina; Iuri, Frias; Reis, Salette. "Development and Characterization of Innovative Lipid Nanocarrier-Based Epigallocatechin gallate delivery system for preventive and therapeutic supplementation". Trabalho apresentado em Bio Engineering Conference’14, 2014.
  45. Pinheiro, Marina; Arêde, Mariana; Nunes, Claudia; Caio, João; Monteiro, Cristina; Reis, Salette. "Interactions of Rifabutin and Novel Analogs for Tuberculosis with Membranes: Implications for Mechanism of Action and Drug Development". Trabalho apresentado em NovALIX, 2013.
  46. Pinheiro, Marina; Pereira-Leite, Catarina; Arêde, Mariana; Nunes, Claudia; Caio, João; Moiteiro, C.; Reis, Salette. "Evaluation of the structure-activity relationship of rifabutin and analogues: a drug-membrane study". Trabalho apresentado em IJUP’13, 2013.
  47. Pinheiro, Marina; Arêde, Mariana; Nunes, Claudia; Caio, João; Moiteiro, Cristina; Reis, Salette; Lúcio, Marlene; Giner-Casares, J.J.. "Evaluation of the effects of a rifabutin’s derivate on the biophysical properties of the pulmonary surfactant membrane studied with 2D and 3D model systems". Trabalho apresentado em XVIII Encontro Luso-Galego de Quimica, 2012.
  48. Pinheiro, Marina; Castro, Castro; Giner-Casares, Juan; Lúcio, Marlene; Segundo, Marcela; Camacho, Luís; Reis, Salette. "Study of antioxidante effects at the air-water interface: a biophysical approach to membrane peroxidation". Trabalho apresentado em 22nd IUBMB & 37th FEBS Congress, 2012.
  49. Pinheiro, Marina. "Lipid nanoparticles for topical and transdermal application for celulite treatment". Trabalho apresentado em III Congresso of the Portuguese Society of Pharmaceutical Sciences, 2011.
  50. Pinheiro, Marina. "Lipid monolayers as resourceful tools to study the activity of enzymes and drugs at the interface". Trabalho apresentado em RICI – 4thIberian Meeting on Colloids and Interfaces, 2011.
  51. Pinheiro, Marina. "Biophysical interactions of Rifabutin with phosphatidylcholine (DPPC) monolayers". Trabalho apresentado em III Conference of the Portuguese Society of Pharmaceutical Sciences, 2011.
  52. Pinheiro, Marina. "Membrane biophysical studies as a tool to understand the mechanism of action of antitubercular drugs". Trabalho apresentado em 4th Iberian Meeting on Colloids and Interfaces, 2011.
  53. Pinheiro, Marina. "Liposomes as membrane models: biophysical interactions with rifabutin". Trabalho apresentado em Liposomes Jerusalem, 2011.
  54. Pinheiro, Marina. "Drug-membrane interaction studies applied to a newly synthesized rifabutin derivative". Trabalho apresentado em XVI Encontro Luso-Galego de Química, 2010.
  55. Pinheiro, Marina. "Fucus spiralis : a potential treasure from the sea?". Trabalho apresentado em IJUP09 – Second Meeting of Young Researchers of U.Porto, 2009.
  56. Pinheiro, Marina; Filipa Grosso; S Quinteira; T Bergerová; J Hrabák; Luísa Peixe. "Clonal outbreak of multidrug-resistant ST22 Acinetobacter baumannii in a University Hospital". Trabalho apresentado em 19th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases), 2009.
Tese / Dissertação
  1. Faculdade de Farmácia. ""Interactions of Rifabutin and Novel Analogs for Tuberculosis with Membranes: Implications for Mechanism of Action and Drug Development"". Doutoramento, 2013. http://hdl.handle.net/10216/71811.

Propriedade Intelectual

Pedido provisório de patente
  1. 2021. "Colorimetric nanosensor for SARS-Cov-2 (NPAT404/2020)".
    Protegido
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2022/07/29 Seasonal Health-Specific Contingency Plan Plano de Contingência Específico Saúde Sazonal 2022: sessão de esclarecimento
Residential Structures for Elderly People (Barcelos, Portugal)
2020/08/06 In vitro models of biological barriers for health sciences applications (Invited presenting author) PUC-Rio
University of Rio de Janeiro, Brazil (Rio de Janeiro, Brasil)
2020/02/13 Serine-based surfactants as potential drug delivery and antimicrobial agents IJUP – Encontro Investigação Jovem da Universidade do Porto
(Portugal)
2019/06/27 Lipid nanoparticles biocompatibility: do in vitro and in vivo studies reveal the same info? 7th Advanced Summer School: Interrogations at the Biointerface - Do organoids fill the in vivo/in vitro gap?
2019/05/21 Pulmonary barrier: practical aspects (Invited presenting author) In vitro models of biological barriers for Health Sciences Applications
Faculdade de Farmácia da Universidade do Porto (porto, Portugal)
2019/05/21 The pulmonary barrier Advanced course on In vitro Models of Biological Barriers for Health Sciences Application
Faculdade de Farmácia da Universidade do Porto (porto, Portugal)
2019/02/12 Serine-based surfactants as potential drug delivery and antimicrobial agents. IJUP – Encontro Investigação Jovem da Universidade do Porto
(porto, Portugal)
2018/06/26 Lipids in infectious diseases: the case of tuberculosis Biofísica Membranar: Impacto dos Lípidos na Saúde, Doença e Terapia
FFUP (Portugal)
2017/07/24 Biophysics in tuberculosis: implications of drug-membrane interaction for the mechanism of action and drug development (Invited presenting author) Biofísica Membranar: Impacto dos Lípidos na Saúde, Doença e Terapia
FFUP
2016/11/11 Targeted nanostructured lipid carriers based epigallocatechin gallate delivery system to cancer cells XXII Encontro Luso-Galego de Química
(Bragança, Portugal)
2016/02/19 Biophysical study of the effect of modified cel-penetrating peptides on lipid membrane IJUP – Encontro Investigação Jovem da Universidade do Porto
(Porto, Portugal)
2015/02/11 Development of lipid nanocarriers-based epigallocatechin gallate for preventive and therapeutic supplementation NanoPT
(Porto, Portugal)
2014/05/21 The application of monolayer studies in the understanding of drug-membrane interaction (Invited presenting author) 3rd Workshop in Lipidomics
(Aveiro, Portugal)
2014/05/21 Applications of liposomes in drug development 3rd Workshop in Lipidomics
(Aveiro, Portugal)
2014/05/14 Nanomedicine for tuberculosis: liposomes as drug delivery systems (Invited presenting author) 3º Encontro de Biotecnologia microbiana e farmacêutica
(Porto, Portugal)
2014/03/23 Molecular and characterization of drugs-lipid membrane model interactions 1st Annual Conference of the COST action MP1302 Nanospetroscopy
(Tubingen, Alemanha)
2013 Evaluation of isoniazid and rifampicin on the biophysical properties of the membrane studied with 3D model systems XIX Encontro Luso-Galego de Química
(Vigo, Espanha)
2013 Diferentes interacções da rifampicina com modelos membraneres de acordo com o pH: implicação para o seu efeito terapêutico e tóxico XIX Encontro Luso-Galego de Química
(Vigo, Espanha)
2013 Development and characterization of nanocarrier systems for the delivery of antituberculosis drugs XIX Encontro Luso-Galego de Química
(Vigo, Espanha)
2012/09/25 The interactions of antimycobacterial compounds with membranes: implications for its therapeutic and toxic effects (Invited presenting author) CEF Centro de estudos farmacêuticos
(Coimbra, Portugal)
2012/02/12 Interactions of acylated S413-PV analogs with lipid membranes XV EPI- Encontro Peptídico Ibérico
(Porto, Portugal)
2012 Effect of biological antioxidants in lipid monolayers: a biophysical approach to membrane properties using phosphatidylcholine XVIII Encontro Luso-Galego de Química
(Vila Real, Portugal)
2011/11/20 Optimization of nanostructured lipid carriers loaded with rifapentine: a tool for pulmonary tuberculosis therapy XXI Encontro Luso Galego de Química
(Pontevedra, Espanha)
2011/02/17 Rifabutin and analogue: fluorescence and x-ray studies reveal drug-membrane interactions 4th Meeting of young researchers at up - IJUP’11
(Porto, Portugal)
2011 Liposomes as versatile membrane model systems to assess therapeutics RICI – 4thIberian Meeting on Colloids and Interfaces
(Porto, Portugal)
2011 Pulmonary surfactant biophysical changes induced by rifabutin and analogue Encontro Luso-Galego de Química
(Pontevedra, Espanha)
2011 The effect of anti-tuberculosis drugs and mycolic acids on Cursourf monolayers XVII Encontro Luso-Galego de Química
(Pontevedra, Espanha)
2011 Uso de sistemas membranares para a previsão de parâmetros farmcodinâmicos e farmacocinéticos de fármacos VI Congresso Científico da AEFFUP
(Porto, Portugal)
2010 Biophysical interactions with lipid membrane models: new tools and methodologies for assessing therapeutics XVI Encontro Luso-Galego de Química
(Aveiro, Portugal)
2010 Interaction of N’-acetyl rifabutin with large unilamellar liposomes: partition and fluorescence studies reveal the importance of charge interactions XVI Encontro Luso-Galego de Química
(Aveiro, Portugal)
2010 Differential interaction of rifabutin with lipids of varying surface charges: an aspect related to its antimicrobial activity XVI Encontro Luso-Galego de Química
(Aveiro, Portugal)
2010 Membranes as meeting points for the action and toxicity of therapeutics XVI Encontro Luso-Galego de Química
(Aveiro, Portugal)

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2018/08/01 - Atual Nanomedicine as a multifunctional platform for the treatment of drug-sensitive and multidrug resistant tuberculosis
Orientador
2016 - Atual “Breast cancer synergistic therapy based on targeted lipid nanoparticles”
Coorientador
 Programa Doutoral em Biotecnologia Molecular e Celular Aplicada às Ciências da Saúde (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014/09/01 - Atual “Nanostructured lipid carriers as drug delivery systems for the treatment of pulmonary tuberculosis”.
Coorientador
 International Doctoral Programme in Molecular and Cellular Biotechnology Applied to Health Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2023/03 - 2023/06 Predictors factors of non-compliance screening for colon and rectal cancer in the context of primary health care: a neested case control study in a cohort
Orientador
 Estatística Aplicada (Licenciatura/Bacharelato)
Universidade do Minho, Portugal
2023/03 - 2023/05 Passive targeting drug delivery to macrophages using lipid nanoparticles for the treatment of infectious diseases
Orientador
 Medicina (Mestrado)
Universidade do Algarve, Portugal
2022/03 - 2022/04 Lipid nanoparticles as drug delivery systems of rifampicin for the treatment of tuberculosis
Orientador
 Medicine
Universidade do Algarve, Portugal
2022/03 - 2022/03 Lipid nanoparticles as a promising rifapentine drug delivery carrier to treat tuberculosis
Orientador
 Medicine (Licenciatura/Bacharelato)
Universidade do Algarve, Portugal
2020/01/01 - 2020/04/30 Current vaccines in clinical trials and novel vaccines as a novel approach for the immunization of tuberculosis
Coorientador
 Medicine (Licenciatura/Bacharelato)
Universidade do Algarve, Portugal
2020/01/01 - 2020/04/30 Nanomedicine in metastatic breast cancer
Orientador
 Estudos Básicos de Medicina (Licenciatura/Bacharelato)
Universidade do Algarve, Portugal
2018/11/20 - 2019/09/19 Nanopartículas como sistemas de libertação de fármacos anti-tuberculosos através da via de administração inalatória
Orientador
 Bioquímica (Outra)
Universidade do Porto Faculdade de Ciências, Portugal
2015/09/01 - 2019/04/04 "Targeting Antimalarial eX-star drugs for Intracellular delivery"
Coorientador
 Doutoramento em Química Sustentável (Doutoramento)
Universidade do Porto Faculdade de Ciências, Portugal
2018/12/01 - 2019/01/06 Nanomedicine for the treatment of breast cancer: drug delivery of lapatinib using nanostructured lipid carriers¿.
Orientador
 Medicina (Iniciação científica)
Universidade do Algarve, Portugal
2018/12/01 - 2019/01/06 Development of Lipid Nanoparticles as Drug Delivery Systems against Tuberculosis¿
Orientador
 Medicina (Iniciação científica)
Universidade do Algarve Escola Superior de Saúde, Portugal
2017/12/01 - 2018/06/01 “Molecular interactions of epigallocatechin gallate with lipid membrane models”
Orientador
 Medicina (Iniciação científica)
Universidade do Algarve Escola Superior de Saúde, Portugal
2017/12/01 - 2018/01/06 “Interacção fármaco-membrana da rifapentina”
Orientador
 Medicina (Iniciação científica)
Universidade do Algarve Escola Superior de Saúde, Portugal
2014 - 2017 "Design, development and characterization of innovative lipid nanoparticles for the treatment of tuberculosis”.
Coorientador
 Ciências Farmacêuticas (Licenciatura/Bacharelato)
Universidade do Porto Faculdade de Farmácia, Portugal
2014 - 2017 “Nanostructured lipid carriers as drug delivery system of Isoniazid for pulmonary administration: a tool to overcome the drawbacks of tuberculosis treatment”
Orientador
 Ciências Farmacêuticas (Licenciatura/Bacharelato)
Universidade do Porto Faculdade de Farmácia, Portugal
2015 - 2016/07/22 “Targeted nanostructured lipid carriers based epigallocatechin gallate delivery systems to cancer cells.” Integrated Master in Bioengeneering (Mestrado)
Universidade do Porto Faculdade de Engenharia, Portugal
2015 - 2015 “Targeted nanostructured lipid carriers based epigallocatechin gallate delivery systems to cancer cells.”
Coorientador
 Integrated Master in Bioengeneering (Curso de aperfeiçoamento / especialização)
Universidade do Porto Faculdade de Engenharia, Portugal
2013 - 2014/10/13 “Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.”
Coorientador
 Integrated Master in Bioengeneering (Mestrado)
Universidade do Porto Faculdade de Engenharia, Portugal
2012 - 2013/07/22 “Evaluation of isoniazid on the biophysical properties of the membrane studied with 3D model systems”.
Coorientador
 Integrated Master in Bioengeneering
Universidade do Porto Faculdade de Engenharia, Portugal
2012 - 2013 “Development and Characterization of Nanocarrier Systems for the Delivery of Antitubercular Drugs”.
Coorientador
 Integrated Master in Bioengeneering (Mestrado)
Universidade do Porto Faculdade de Engenharia, Portugal
2012 - 2013 “Evaluation of rifampicin on the biophysical properties of the membrane studied with 3D model systems”
Coorientador
 Ciências Farmacêuticas (Curso de aperfeiçoamento / especialização)
Universidade do Porto Faculdade de Farmácia, Portugal
2012 - 2012 “Development and Characterization of “Development and Characterization of Nanocarrier Systems for the Delivery of Antitubercular Drugs”.Nanocarrier Systems for the Delivery of Antitubercular Drugs”.
Coorientador
 Integrated Master in Bioengeneering (Curso de aperfeiçoamento / especialização)
Universidade do Porto Faculdade de Engenharia, Portugal
2011 - 2012 “Interação de derivados da rifabutina com modelos de surfactante pulmonar: uma abordagem biofísica”.
Coorientador
 Ciências Farmacêuticas (Curso de aperfeiçoamento / especialização)
Universidade do Porto Faculdade de Farmácia, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2022/05/06 - Atual Space.Minho 2022: Health and Human Challenges (2022/05/06 - 2022/05/06)
Encontro (Membro da Comissão Organizadora)
 Universidade do Minho, Portugal
2023/05/24 - 2023/05/26 National Meeting of Public Health Interns (2023/05/24 - 2023/05/26)
Conferência (Coorganizador)
2019/07/09 - 2019/07/09 Chemopreventive activity of (-)-Epigallocatechin-3-gallate (EGCG): molecular mechanisms and potentiality (2019/07/09 - 2019/07/09)
Conferência (Presidente da Comissão Organizadora)
 Faculdade de Farmácia da Universidade do Porto, Portugal
2019/06/12 - 2019/06/14 Protein-Ligand Interactions: From Theory to Practice (2019/06/12 - 2019/06/14)
Conferência
 Faculdade de Farmácia da Universidade do Porto, Portugal
2019/05/21 - 2019/05/24 In vitro Models of Biological Barriers for Health Sciences Applications (2019/05/21 - 2019/05/24)
Conferência (Membro da Comissão Organizadora)
 Faculdade de Farmácia da Universidade do Porto, Portugal
2018/06/22 - 2018/06/26 Summer course entitled “Biofísica Membranar: Impacto dos Lípidos na Saúde, Doença e Terapia” 3 ECTS. (2018/01/01 - 2018/06/26)
Conferência (Membro da Comissão Organizadora)
 Faculdade de Farmácia da Universidade do Porto, Portugal
2017/07/23 - 2017/07/27 Summer course entitled “Biofísica Membranar: Impacto dos Lípidos na Saúde, Doença e Terapia” (2017/01/01 - 2017/07/27)
Congresso (Membro da Comissão Organizadora)
 Universidade do Porto Faculdade de Farmácia, Portugal
2014/05/14 - 2014/05/14 3º Encontro de Biotecnologia microbiana e farmacêutica (2014/04/14 - 2014/05/14)
Conferência (Membro da Comissão Organizadora)
 Universidade do Porto Faculdade de Farmácia, Portugal

Participação em evento

Descrição da atividade
Tipo de evento 		Nome do evento
Instituição / Organização
2022/03/03 - 2022/03/03 Panel discussion on global burden of TB
European Respiratory Society, Suiça
2019/04/07 - 2019/04/12 Short Mission to Evaluate nanomedicine efficacy in 3D breast tumor models with Brillouin light scattering in Univerity of Lyon, France. 07-12th of April, 2019.
Université de Lyon, França
2018/11/11 - 2018/11/13 Scientific internship under the supervision of Professor Barbara Rothen-Rutishauser
Université de Fribourg Adolphe Merkle Institute, Suiça
2018/05/01 - 2018/05/30 Scientific internship under the supervision of Professor Ben Forbes. King’s College, London UK.
King's College London, Reino Unido
2014/07/01 - 2014/07/06 Scientific internship to the determination of X-ray reflectivity and Grazing incidence X-ray diffraction (GIXD) in a synchrotron. Soleil, Paris, France.
Synchrotron SOLEIL, França
2014/06/01 - 2014/06/05 Scientific internship to the determination of small and wide angle X-ray diffraction (SAXS and WAXS) in a synchrotron. Elletra, Trieste, Italy.
Elletra , Itália
2012/12/15 - 2012/12/24 Scientific internship in the Max-Planck Institute for colloids and interfaces, Golm, Germany.
Max-Planck-Institut für Kolloid- und Grenzflächenforschung, Alemanha
2012/08/02 - 2012/08/06 Scientific internship to the determination of small and wide angle X-ray diffraction (SAXS and WAXS) in a synchrotron. HASYLAB, DESY, Hamburg, Germany.
HASYLAB at Deutsches Elektronen-Synchrotron DESY , Alemanha
2012/07/13 - 2012/07/17 Scientific internship to the determination of X-ray reflectivity and Grazing incidence X-ray diffraction (GIXD) in a synchrotron. HASYLAB, DESY, Hamburg, Germany.
HASYLAB at Deutsches Elektronen-Synchrotron DESY , Alemanha
2011/10/14 - 2011/10/17 Scientific internship to the determination of X-ray reflectivity and Grazing incidence X-ray diffraction (GIXD) in a synchrotron. HASYLAB, DESY, Hamburg, Germany.
HASYLAB at Deutsches Elektronen-Synchrotron DESY , Alemanha
2011/05/01 - 2011/07/31 Scientific internship in the University of Cordoba Departamento: Química Física y Termodinámica for 3 months.
Universidad de Córdoba, Espanha
2010/10/26 - 2010/10/28 Participation in the IIIrd Training School on Bioencapsulation. University of Nantes in France.
Université de Nantes, França
2010/05/14 - 2010/05/19 Scientific internship to the determination of X-ray reflectivity and Grazing incidence X-ray diffraction (GIXD) in a synchrotron. HASYLAB, DESY, Hamburg, Germany.
HASYLAB at Deutsches Elektronen-Synchrotron DESY , Alemanha
2010/04/12 - 2010/04/12 Monitor in Practice class: “Técnicas electroquímicas, condutimetria e potenciometria” to the master in Quality Control students. FFUP– University of Porto.
Universidade do Porto Faculdade de Farmácia, Portugal
2010/03/27 - 2010/03/27 Teaching Assistant: “Técnicas espectrais ópticas de análise molecular - Fluorimetria” to the master in Quality Control students. FFUP– University of Porto.
Universidade do Porto Faculdade de Farmácia, Portugal
2010/03/26 - 2010/03/26 Teaching Assistant: “Técnicas espectrais ópticas de análise molecular - Fluorimetria” to the master in Quality Control students. FFUP– University of Porto.
Universidade do Porto Faculdade de Farmácia, Portugal
2009/04/01 - 2009/07/31 Community pharmacy training in Instituto Galênico Português, Braga.
Instituto Galênico Português, Portugal
2009/02/01 - 2009/03/31 Hospital pharmacy training. Hospital de São João, E.P.E., Porto.
Centro Hospitalar de São João EPE, Portugal
2007/09/01 - 2009/02/01 Volunteer researcher in the microbiology and resistance to antibiotics unit. Department of Microbiology of FFUP– University of Porto .
Universidade do Porto Faculdade de Farmácia, Portugal
2007/08/01 - 2007/08/15 Volunteer researcher in Instituto de Águas da Região Norte (I.A.R.E.N.) – Matosinhos.
Instituto da água da região norte, Portugal
2002/07/01 - 2003/05/31 Volunteer in a Senior Center.
2000/07/01 - 2000/07/15 Volunteer in a school. Escola básica do 1º ciclo da Sé.

Júri de grau académico

Tema
Tipo de participação 		Nome do candidato (Tipo de grau)
Instituição / Organização
2023/12/14 Green graphene quantum dots for cancer imaging and treatment
Arguente principal
 Bruna Daniela Gonçalves Martins (Mestrado)
Universidade do Minho, Portugal
2020/12/04 Exploring novel approaches to tackle Mycobacterium avium
Arguente principal
 Jorge Oliveira (Mestrado)
2019/06/11 NSAIDS associated with protective mediators: pharmacological actions on lipid membranes
Arguente principal
 Beatriz Gomes (Outro)
Faculdade de Farmácia da Universidade do Porto, Portugal
2019/06/10 Putting membrane lipids on the radar of drug development: the case of nonsteroidal anti-inflammatory drugs associated with protective mediators
Arguente principal
 Márcia Martins (Outro)
Faculdade de Ciências da Universidade do Porto, Portugal
2019/02/27 Membrane permeabilization: a role in drug-induced cardiovascular toxicity?
Arguente principal
 Marina Figueiredo (Outro)
Universidade do Porto Faculdade de Farmácia, Portugal
2018/10/12 "Development of an anti-adhesive coating using an extracellular polymer produced by a Cyanobacterium: towards industrial application”
Arguente principal
 Jorge Cardoso (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/02/26 “NSAIDs cardiovascular risk: a role for drug effects on membranes?”
Arguente principal
 João Almeida (Outro)
Universidade do Porto Faculdade de Farmácia, Portugal
2017/11/03 “Nanocarriers as alternative strategies for the treatment of mycobacterial infectious”
Arguente
 Alexandre Couto (Doutoramento)
Universidade do Porto Faculdade de Farmácia, Portugal
2016/12/21 “Paclitaxel loaded hybrid magnetic- lipid nanoparticles as a novel approach for breast cancer therapy”.
Arguente principal
 Ana Rita Leal (Mestrado)
Universidade do Porto Faculdade de Engenharia, Portugal

Arbitragem científica em conferência

Nome da conferência Local da conferência
2023/05/03 - 2023/05/05 17th World Congress on Public Health Rome

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2022/03/02 - Atual Portuguese Journal of Cardiac Thoracic and Vascular Surgery
2020/01/27 - Atual Nanoscale (2040-3372) The Royal Society of Chemistry
2020/01/18 - Atual ACS Applied Materials & Interfaces (1944-8252) American Chemical Society
2019/03/31 - Atual International Journal of Pharmaceutics (0378-5173) Elsevier
2019/02/25 - Atual Cancers (2072-6694) MDPI AG
2019/02/07 - Atual Journal of Drug Delivery Science and Technology (1773-2247) Elsevier
2018/10/05 - Atual Biomedicine & Pharmacotherapy (0753-3322) Elsevier
2018/06/04 - Atual Current Clinical Pharmacology (1574-8847) Bentham Science
2018/04/12 - Atual Biomedicines (2227-9059) MDPI AG
2018/01/02 - Atual Chemico-Biological Interactions (0009-2797) Elsevier
2016/03/04 - Atual IET Nanobiotechnology (1751-875X) Institution of Electrical Engineers
2016/01/03 - Atual Molecules (1420-3049) MDPI AG
2015/04/05 - Atual Nutrients (2072-6643) MDPI AG
2014/02/01 - Atual Pharmazie in unserer Zeit (1615-1003) Wiley (John Wiley & Sons)
2019/02/03 - 2019/02/06 ACS Omega (2470-1343) American Chemical Society
2018/11/03 - 2019/01/08 Pharmaceutics (1999-4923) MDPI AG
2018/09/15 - 2019/01/03 International Journal of Molecular Sciences (1422-0067) MDPI AG
2018/08/28 - 2018/12/28 Critical Reviews in Food Science and Nutrition (1549-7852) Informa UK (Taylor & Francis)
2018/08/28 - 2018/10/08 RSC Advances (2046-2069) The Royal Society of Chemistry
2018/01/05 - 2018/07/04 PLoS ONE (1932-6203) Public Library of Science
2018/01/05 - 2018/04/03 Science of Advanced Materials (1947-2943) American Scientific Publishers
2017/04/03 - 2017/10/02 International Journal of Nanomedicine (1178-2013) Dove Medical Press
2016/01/19 - 2016/06/07 EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS Elsevier

Comissão de avaliação

Descrição da atividade
Tipo de assessoria 		Instituição / Organização Entidade financiadora
2024/01 - Atual World Health Organization - Division of UHC/Healthier Populations
Especialista
 World Health Organization
2023/03/01 - Atual La Caixa Foundation Fellowships
Especialista
 CaixaForum Barcelona, Espanha CaixaForum Barcelona
2023/03/01 - Atual EU Health Research Programme - Horizon 2020 European Commission, Bélgica European Commission
2020/01/01 - Atual Expert in the European Commission (EX2019D365280)
Avaliador
 European Commission, Bélgica
2021/03/02 - 2021/03/02 3rd Management Committee Meeting/2nd Working Groups Meeting in Heraklion, Crete, Greece. European Cooperation in Science and Technology, Bélgica
2020/03/16 - 2020/03/17 COST 2nd Management Committee Meeting/ 1st Working Groups Meeting (Clare College, Memorial Court, Queens Road, Cambridge CB3 9AJ UK, Cambridge, United Kingdom)
Especialista
 European Cooperation in Science and Technology, Bélgica
2015/11/15 - 2015/12/17 Evaluation process FONDECYT Regular Competition
Avaliador
 Comisión Nacional de Investigación Científica y Tecnológica, Chile
2014/07/28 - 2014/10/03 South African MRC SIR Grant Applications for Review
Avaliador
 National Research Foundation, África do Sul

Consultoria / Parecer

Descrição da atividade Instituição / Organização
2023/12/06 - Atual Ethics and Research Integrity Policy in Responsible Research Assessment for Data and Artificial Intelligence (ERIP) WG in Coalition for advancing research assessment (COARA)
2022/02/01 - Atual Editor in Biomedicines
2022/01/01 - Atual Editor in Frontiers Microbiology
2021/07/01 - Atual Expert of the Lithuanian Research Council
2021/02/01 - Atual Guest-editor of the Journal of the Journal of Immunology Research
2021/01 - Atual Guest-editor in Cancers Multidisciplinary Digital Publishing Institute AG, Suiça
2020/08 - Atual Guest-editor Frontiers Frontiers Foundation, Canadá
2020/07 - Atual Academic Editor of BioMed Research International Hindawi Publishing Corp New York Office, Estados Unidos
2020/01/01 - Atual Reviewer board member of Pharmaceutics Multidisciplinary Digital Publishing Institute AG, Suiça
2020/01 - Atual Academic editor Membranes Multidisciplinary Digital Publishing Institute AG, Suiça
2019/03 - Atual Editor Plos One Plos one, Estados Unidos
2021/02 - 2023/02 Consultant of the Science Fund of the Republic of Serbia

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2019/06/12 - 2019/06/14 Protein-Ligand Interactions: From Theory to Practice (Pós-Graduação) Universidade do Porto Faculdade de Farmácia, Portugal
2019/05/21 - 2019/05/24 In vitro Models of Biological Barriers for Health Sciences Applications (Pós-Graduação) Universidade do Porto Faculdade de Farmácia, Portugal
2014/02/01 - 2014/07/31 Assistant Professor of Analytical Chemistry, Faculdade de Farmácia da Universidade do Porto. Pharmaceutical Sciences (Mestrado integrado) Universidade do Porto Faculdade de Farmácia, Portugal
2013/11/15 - 2013/11/15 Guest Lecturer entitled “Respiratory diseases” to the Master in Bioengineering students. ICBAS – University of Porto Bioengineering (Mestrado integrado) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013/05/17 - 2013/05/17 Guest Lecturer entitled “Respiratory diseases” to the Master in Bioengineering students. FEUP – University of Porto. Bioengineering (Mestrado integrado) Universidade do Porto Faculdade de Engenharia, Portugal
2013/02/14 - 2013/02/14 Guest Lecturer entitled “Respiratory diseases” to the Master in Pharmaceutical Sciences students. FFUP – University of Porto. Pharmaceutical Sciences Universidade do Porto Faculdade de Farmácia, Portugal
2011/04/07 - 2011/04/11 Optical Microscopy Imaging for Biosciences. I3S. Porto, Portugal. (Curso de Especialização Tecnológica) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Membro de associação

Nome da associação Tipo de participação
2022/03/01 - Atual Saúde+Pública Podcast section
2022/02/24 - Atual Associação Nacional dos Médicos de Saúde Pública Communication member
2020/09/01 - Atual Ordem dos Médicos
2019/09/01 - Atual Pint of Science Event Manager
2018/08/01 - Atual American Chemical Society (ACS) Member

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2020/11 - Atual Academic Editor in Acta Médica (Pharmacology specialist)
Consultor
 Ordem dos Médicos, Portugal
2019/08 - Atual MC Member in the Cost Action CA18233 - European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias.
Membro
 Associação para a Inovação e Desenvolvimento da FCT, Portugal
2019/03 - Atual Supervisor Member of the International Doctoral Programme in Molecular and Cellular Biotechnology Applied to Health Sciences
Membro
 Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019 - Atual Global Burden Diseases (GBD)
Membro
 Institute for Health Metrics and Evaluation (IHME) at the University of Washington , Estados Unidos
2005 - 2007 CEO of Junipharma (Go Pharma). JADE Portugal.

Outro júri / avaliação

Descrição da atividade Instituição / Organização
2020/01/01 - Atual Academic Editor of Membranes Multidisciplinary Digital Publishing Institute AG, Suiça
2019/02/01 - Atual Academic Editor of Plos One Public Library of Science, Estados Unidos
Distinções

Prémio

2022 Best poster award (honorable mention; 2nd place of best poster award) - Sociodemographic characterization, access and results in health of the gypsy population of Barcelos, Portugal in 2021
Public Health Unit - ACES Baixo Vouga, Portugal
2019 Universidades e Instituições de Ensino Superior da Eurorregião Galicia-Norte de Portugal (IACOBUS)
2019 Short Term Mission Travel Grant
European Cooperation in Science and Technology, Bélgica
2018 Best Poster award honourable mention
University of Porto., Portugal
2013 FCT post-doctoral grant (SFRH / BPD / 99124)
Fundação para a Ciência e a Tecnologia, Portugal
2009 FCT PhD grant (SFRH / BD / 63318 / 2009)
Fundação para a Ciência e a Tecnologia, Portugal

Outra distinção

2019 Merit writing recognition
2014 Medscape Medical News publication (https://www.medscape.com/viewarticle/752329_7)
Medscape LLC, Estados Unidos